BBVA USA

SEC CIK: 0000844928
Latest filing: Nov 4, 2021

SEC filings (opens in a new tab)

ALXN holding history

Alexion Pharmaceuticals, Inc. in every 13F filed by BBVA USA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALXN overview All 13F holders of ALXN Full Q3 2021 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q2 2021

Holdings of ALXN by BBVA USA, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−667−100.0%	Sold out	Holders
Q2 2021	667	$123.0K	<0.1%	–	No prior filing	Holders